Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment remaining a challenge despite decades of research. For years, the prostate-specific ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study ...

A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...

Diagnoses of prostate cancer overtook breast cancer in 2022 and 2023, according to the charity Prostate Cancer UK.

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...